1. Home
  2. RDHL vs UGRO Comparison

RDHL vs UGRO Comparison

Compare RDHL & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • UGRO
  • Stock Information
  • Founded
  • RDHL 2009
  • UGRO 2014
  • Country
  • RDHL Israel
  • UGRO United States
  • Employees
  • RDHL N/A
  • UGRO N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • UGRO Industrial Specialties
  • Sector
  • RDHL Health Care
  • UGRO Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • UGRO Nasdaq
  • Market Cap
  • RDHL 4.3M
  • UGRO 3.8M
  • IPO Year
  • RDHL N/A
  • UGRO N/A
  • Fundamental
  • Price
  • RDHL $1.91
  • UGRO $0.34
  • Analyst Decision
  • RDHL
  • UGRO Strong Buy
  • Analyst Count
  • RDHL 0
  • UGRO 1
  • Target Price
  • RDHL N/A
  • UGRO $3.00
  • AVG Volume (30 Days)
  • RDHL 15.6K
  • UGRO 580.0K
  • Earning Date
  • RDHL 08-28-2025
  • UGRO 07-22-2025
  • Dividend Yield
  • RDHL N/A
  • UGRO N/A
  • EPS Growth
  • RDHL N/A
  • UGRO N/A
  • EPS
  • RDHL N/A
  • UGRO N/A
  • Revenue
  • RDHL $8,042,999.00
  • UGRO $59,985,138.00
  • Revenue This Year
  • RDHL $381.91
  • UGRO N/A
  • Revenue Next Year
  • RDHL N/A
  • UGRO $31.25
  • P/E Ratio
  • RDHL N/A
  • UGRO N/A
  • Revenue Growth
  • RDHL 23.17
  • UGRO N/A
  • 52 Week Low
  • RDHL $1.71
  • UGRO $0.26
  • 52 Week High
  • RDHL $20.28
  • UGRO $1.92
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 44.55
  • UGRO 50.16
  • Support Level
  • RDHL $2.00
  • UGRO $0.31
  • Resistance Level
  • RDHL $2.08
  • UGRO $0.35
  • Average True Range (ATR)
  • RDHL 0.10
  • UGRO 0.04
  • MACD
  • RDHL 0.01
  • UGRO 0.01
  • Stochastic Oscillator
  • RDHL 37.05
  • UGRO 38.88

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.

About UGRO urban-gro Inc.

Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.

Share on Social Networks: